Evaluating LP-10 in Subjects With OLP
Clinical trial NCT06233591 · UNKNOWN
Trial details
- NCT number
- NCT06233591
- Sponsor
- Lipella Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-06-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.